CAS 98651-66-2
:Halobétasol
- (6α,11β,16β)-21-Chloro-6,9-difluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
- Halobetasol
- Pregna-1,4-diene-3,20-dione, 21-chloro-6,9-difluoro-11,17-dihydroxy-16-methyl-, (6α,11β,16β)-
- Unii-9P6159Hm7T
- Ulobetasol
- HALOBETASOL PROPIOTE
- Ulobetasol [inn]
- 21-Chloro Diflorasone
- (6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
- Diflorasone 21-Chloro
Halobetasol
CAS :Formule :C22H27ClF2O4Couleur et forme :White To Off-White SolidMasse moléculaire :428.90Halobetasol
CAS :Produit contrôléStability Hygroscopic
Applications Halobetasol is a corticosteroid, an anti-inflammatory drug that is used to treat various dermatological conditions which mainly consist of various forms of psoriasis.
References Marrero-Ponce, Y. et al.: Eur. J. Med. Chem., 46, 5736 (2011); Spuls, P. I. et al.: J. Dermatolog. Treat., 14, 21 (2003); Wong, J. et al.: J. Drugs, Dermatol., 11, 957 (2012);Formule :C22H27ClF2O4Couleur et forme :NeatMasse moléculaire :428.9Halobetasol-d3
CAS :Produit contrôléApplications Halobetasol is a corticosteroid, an anti-inflammatory drug that is used to treat various dermatological conditions which mainly consist of various forms of psoriasis. This is the labelled isomer.
References Marrero-Ponce, Y. et al.: Eur. J. Med. Chem., 46, 5736 (2011); Spuls, P. I. et al.: J. Dermatolog. Treat., 14, 21 (2003); Wong, J. et al.: J. Drugs, Dermatol., 11, 957 (2012);Formule :C22D3H24ClF2O4Couleur et forme :NeatMasse moléculaire :431.916Halobetasol
CAS :Produit contrôléHalobetasol is a corticosteroid that is used to treat inflammatory skin diseases and bowel disease. It is available in the form of halobetasol propionate. Halobetasol propionate has been shown to be effective for psoriasis, atopic dermatitis, and other forms of inflammatory skin disease. In addition, it is also used to treat bowel disease such as ulcerative colitis and Crohn's disease. The side effects of this drug may include skin thinning, stretch marks, bruising, or an increase in blood pressure. This drug should not be taken by people with autoimmune diseases or infectious diseases. Halobetasol propionate can cause a decrease in the number of white blood cells (leukopenia), which makes it unsuitable for use in patients with conditions that require a high level of white cells (such as HIV).Formule :C22H27ClF2O4Degré de pureté :Min. 95%Masse moléculaire :428.9 g/molHalobetasol
CAS :Halobetasol (Ulobetasol), a corticosteroid, is utilized in the research of severe localized psoriasis [1].Formule :C22H27ClF2O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :428.9



